We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
-0.75%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$111B
AUM Growth
-$5.05B
Cap. Flow
-$8.92B
Cap. Flow %
-8.05%
Top 10 Hldgs %
9.24%
Holding
5,618
New
915
Increased
1,819
Reduced
1,634
Closed
695

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.07B
2
AMZN icon
Amazon
AMZN
+$486M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$443M
4
CRM icon
Salesforce
CRM
+$363M
5
QCOM icon
Qualcomm
QCOM
+$352M

Sector Composition

Rank Sector Weight
1 Technology 14.27%
2 Consumer Discretionary 9.91%
3 Healthcare 7.11%
4 Financials 6.94%
5 Communication Services 6.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FCAX.WS
4751
DELISTED
Fortress Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
FCAX.WS
$18K ﹤0.01%
20,000
TINV.WS
4752
DELISTED
Tiga Acquisition Corp. Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
TINV.WS
$18K ﹤0.01%
25,446
PTE
4753
DELISTED
PolarityTE, Inc. Common Stock
PTE
$18K ﹤0.01%
1,065
+659
+162% +$12.8K
BXRX
4754
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$18K ﹤0.01%
23
-7
-23% -$6.09K
OCAXW
4755
DELISTED
OCA Acquisition Corp. Warrant
OCAXW
$17K ﹤0.01%
32,284
SNDL icon
4756
Sundial Growers
SNDL
$325M
$16K ﹤0.01%
2,400
-1
-0% -$8
ACII.WS
4757
DELISTED
Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50
ACII.WS
$16K ﹤0.01%
+19,172
New +$20.3K
NEPT
4758
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$15K ﹤0.01%
19
+12
+171% +$12.7K
TCACW
4759
DELISTED
Tuatara Capital Acquisition Corporation Warrant
TCACW
$14K ﹤0.01%
25,000
COVAW
4760
DELISTED
COVA Acquisition Corp. Warrants to purchase Class A ordinary shares
COVAW
$12K ﹤0.01%
+20,340
New +$14.3K
DLCAW
4761
DELISTED
Deep Lake Capital Acquisition Corp. Warrant
DLCAW
$11K ﹤0.01%
+14,233
New +$11.4K
FSSIW
4762
DELISTED
Fortistar Sustainable Solutions Corp. Warrant
FSSIW
$11K ﹤0.01%
+16,672
New +$14.7K
NXU.WS
4763
DELISTED
Novus Capital Corporation II Redeemable warrants, each whole warrant exercisable for shares of Class
NXU.WS
$11K ﹤0.01%
+10,359
New +$11.6K
HHLA.WS
4764
DELISTED
HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HHLA.WS
$10K ﹤0.01%
21,200
FSRDW
4765
DELISTED
Fast Radius, Inc. Warrants
FSRDW
$10K ﹤0.01%
+11,898
New +$11.8K
HIPO.WS
4766
DELISTED
Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share
HIPO.WS
$9K ﹤0.01%
+10,000
New +$10.5K
FZT.WS
4767
DELISTED
FAST Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
FZT.WS
$9K ﹤0.01%
10,162
MOBXW icon
4768
Mobix Labs Warrants
MOBXW
$772K
$8K ﹤0.01%
+16,788
New +$7.61K
SPWRW
4769
SunPower Inc Warrants
SPWRW
$1.68M
$8K ﹤0.01%
+12,382
New +$11.6K
POWRW
4770
DELISTED
Powered Brands Warrants
POWRW
$8K ﹤0.01%
+13,072
New +$10.1K
PUCKW
4771
DELISTED
Goal Acquisitions Corp. Warrant
PUCKW
$7K ﹤0.01%
+11,659
New +$7.35K
ZOM
4772
DELISTED
Zomedica Corp.
ZOM
$6K ﹤0.01%
+10,829
New +$6.39K
ACHC icon
4773
Acadia Healthcare
ACHC
$3.17B
-16,003
Closed -$1M
ADM icon
4774
Archer Daniels Midland
ADM
$41.4B
-225,795
Closed -$13.7M
ADMA icon
4775
ADMA Biologics
ADMA
$1.92B
-211,692
Closed -$339K

Similar funds

D.E. Shaw & Co's Q3 2021 Portfolio in Review

As of Q3 2021, D.E. Shaw & Co held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

D.E. Shaw & Co withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, D.E. Shaw & Co opened a new position in Sea Limited worth $206M.

  • D.E. Shaw & Co's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
  • D.E. Shaw & Co added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
  • D.E. Shaw & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
  • D.E. Shaw & Co fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
  • D.E. Shaw & Co's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
  • D.E. Shaw & Co opened 915 new positions and closed 695 in Q3 2021.
  • D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $111B.

Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.